47 participants
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2021-05-24
- Completion:
- 2027-04-01
Conditions
- Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Interventions
- PROCEDURE
- DRUG
- BIOLOGICAL
No Results Yet